Investors Alert : Violin Memory, Inc. (NYSE:VMEM), Wright Medical Group Inc. (NASDAQ:WMGI), Nationstar Mortgage Holdings Inc. (NYSE:NSM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), AT&T, Inc. (NYSE:T)

Violin Memory (NASDAQ:VMEM) has earned an average recommendation of “Hold” from the eight analysts that are covering the company, Analyst Ratings.Net reports. Two investment analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and one has assigned a buy recommendation to the company. Violin Memory, Inc. (NYSE:VMEM) belongs to Technology sector. Its weekly performance is 6.82%. On last trading … Continue reading Investors Alert : Violin Memory, Inc. (NYSE:VMEM), Wright Medical Group Inc. (NASDAQ:WMGI), Nationstar Mortgage Holdings Inc. (NYSE:NSM), Halozyme Therapeutics, Inc. (NASDAQ:HALO), AT&T, Inc. (NYSE:T)

News Buzz : BP p.l.c. (NYSE:BP), Halozyme Therapeutics, Inc. (NASDAQ:HALO), General Cable Corp. (NYSE:BGC), Terreno Realty Corp. (NYSE:TRNO), Proofpoint, Inc. (NASDAQ:PFPT)

On Oct 24, BP p.l.c. (NYSE:BP)’s bid for a new trial over causes of the 2010 Gulf of Mexico oil spill should be rejected because the judge didn’t rely on excluded testimony, Halliburton Co. (HAL) said in court papers. BP p.l.c. (NYSE:BP) belongs to Basic Materials sector. Its net profit margin is 3.00% and weekly performance is 1.92%. On last trading day company shares ended … Continue reading News Buzz : BP p.l.c. (NYSE:BP), Halozyme Therapeutics, Inc. (NASDAQ:HALO), General Cable Corp. (NYSE:BGC), Terreno Realty Corp. (NYSE:TRNO), Proofpoint, Inc. (NASDAQ:PFPT)

clinical trial of halozyme’s PEGPH20 in combination with modified folfirinox for advanced pancreatic cancer. The company announced that the U.S. Food and Drug Administration or FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG’s ongoing Phase 1b/2 clinical trial (S1313). Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its weekly performance is -1.73%. On last trading day company shares … Continue reading Investors Watch List : Halozyme Therapeutics, Inc. (NASDAQ:HALO), Yahoo! Inc. (NASDAQ:YHOO), Otter Tail Corporation (NASDAQ:OTTR), Omnicare Inc. (NYSE:OCR), International Business Machines Corporation (NYSE:IBM),

On July 31,2014 Qualstar Corp. (NASDAQ:QBAK), a designer and manufacturer of high efficiency power supplies, as well as data security and archive storage solutions, announced today that it has expanded its AC-DC power supply offerings by adding the high-efficiency slim line DIN Rail Power Supplies to its N2Power brand product portfolio. Qualstar Corp. (NASDAQ:QBAK) belongs to Technology sector. Its net profit margin is -75.70% and … Continue reading Active Stocks: Qualstar Corp. (NASDAQ:QBAK), Halozyme Therapeutics (NASDAQ:HALO), Elizabeth Arden (NASDAQ:RDEN), Saga Communications Inc. (NYSEMKT:SGA), Escalera Resources Co. (NASDAQ:ESCR)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported that the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock performance was -0.93% in last session and finished the day at $7.42. Traded volume was 3.20million shares in the last session and the … Continue reading Oversold Stocks In News: Halozyme Therapeutics (NASDAQ:HALO), Lumos Networks (NASDAQ:LMOS), Advaxis (NASDAQ:ADXS), Sterling Construction Company (NASDAQ:STRL)

Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter. Though this week’s sales only take us to March 28th, there is enough here for us to assess the sales activity, project some revenue, and look to the pace. Arena Pharmaceuticals, Inc. … Continue reading Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme Therapeutics (NASDAQ:HALO), Gildan Activewear (NYSE:GIL), Ariad Pharmaceuticals (NASDAQ:ARIA)